UF Professor Appointed New Scientific Advisor of Kane Biotech

Kane Biotech Inc., a Canadian-based technology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, announced that Gregory Schultz, Ph.D., has been appointed as a Scientific Advisor.

Dr. Schultz is the director of the Institute for Wound Research and professor of Obstetrics and Gynecology at the University of Florida. Throughout his career, he has conducted research focusing on the molecular and cellular regulators of normal wound healing and developing therapies that reduce excessive scar formation (fibrosis); and understanding the role that bacterial biofilms play in stimulating chronic inflammation and elevated proteases that impair healing in chronic wounds.

Learn more about UF Professor Appointed New Scientific Advisor of Kane Biotech.